Vimarsana
Biggest News Aggregation in the World

Page 27 - Med Express News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Med Express. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Med Express Today - Breaking & Trending Today

PetMed Express, Inc. (NASDAQ:PETS) - ROCE Insights For PetMed Express - Vimarsana News

PetMed Express, Inc. (NASDAQ:PETS) - ROCE Insights For PetMed Express

PetMed Express (NASDAQ:PETS) posted Q3 earnings of $9.29 million, an increase from Q2 of 11.25%. Sales dropped to $65.90 million, a 12.65% decrease between ...

Outlook on the Pet Care E-Commerce Global Market to 2027 - Impact Analysis of COVID-19 - Vimarsana News

Outlook on the Pet Care E-Commerce Global Market to 2027 - Impact Analysis of COVID-19

Share this article Share this article ResearchAndMarkets.com's offering. According to the report, the Global Pet Care E-Commerce Market accounted for $19.52 billion in 2019 and is expected to reach $51.91 billion by 2027, growing at a CAGR of 13% during the forecast period. Growing inclination towards e-commerce websites, increasing annual pet care spending and rise in pet adoption are the major factors propelling the market growth. However, lack of e-commerce adoption and competition against retailers are hampering the market growth. The phenomenon of 'pet humanization' has progressively inc...

AGTC Sheds Light On Achromatopsia Trials, Eli Lilly, VIR And GSK Team Up, CVM Turns Head As It Awaits Data - Vimarsana News

AGTC Sheds Light On Achromatopsia Trials, Eli Lilly, VIR And GSK Team Up, CVM Turns Head As It Awaits Data

(3) LONDON (dpa-AFX) - Today's Daily Dose brings you news about Applied Genetic's Achromatopsia trial results; the deadlock in AstraZeneca vaccine supply in EU; partnership of Lilly, Vir Biotech and GlaxoSmithKline in fighting COVID-19; and ZymeWork's progress with ZW49 study. Read on. 1. Applied Genetic Throws Light on Achromatopsia Trials Applied Genetic Technologies Corp.'s (AGTC) phase I/II clinical trials evaluating AAV gene therapy product candidates in patients with achromatopsia caused by CNGB3 or CNGA3 mutations, dubbed ACHMB3 and ACHMA3 trials, have provided for the first time quan...

3 Stocks to Bankroll Your Retirement - Vimarsana News

3 Stocks to Bankroll Your Retirement

Jan 26, 2021 at 7:07AM Follow @jimhalley When you're choosing the right stocks to help fund your retirement, you need stable, safe income producers -- companies that have steady, if not spectacular growth, with above-average dividend yields. But that doesn't mean you have to buy the same stocks your grandparents did. Ideally, the stocks you pick are on the cusp of trends that are going to climb for years. Where's the growth? You can look for stocks in healthcare, pet care, and 5G technology, just to name a few sectors. Healthcare should be an obvious pick, ...

Source: fool.com
PetMed Express Q3 Profit Matches Estimates; Sales Up 10% - Vimarsana News

PetMed Express Q3 Profit Matches Estimates; Sales Up 10%

PetMed Express Q3 Profit Matches Estimates; Sales Up 10% WASHINGTON (dpa-AFX) - PetMed Express, Inc. (PETS) reported third quarter net income of $7.6 million, or $0.38 per share, compared to net income of $6.8 million, or $0.34 per share, prior year. Analysts polled by Thomson Reuters expected the company to report profit per share of $0.38, for the quarter. Analysts' estimates typically exclude special items. Third quarter net sales were $65.9 million, compared to $59.9 million, a year ago, an increase of 10.0%. Analysts expected revenue of $63.81 million, for the quarter. The Board of Dir...